BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 25318804)

  • 1. Hemoperfusion for Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis.
    Tatara R; Sato M; Fujiwara S; Oh I; Muroi K; Ozawa K; Nagai T
    Intern Med; 2014; 53(20):2365-8. PubMed ID: 25318804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis-a dangerous disease.
    Jin Z; Wang Y; Wei N; Wang Z
    Ann Hematol; 2020 Jul; 99(7):1575-1581. PubMed ID: 32500223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hodgkin's lymphoma preceded by haemophagocytic lymphohistiocytosis.
    Morita Y; Kenzaka T; Yoshimoto H; Ohno N
    BMJ Case Rep; 2013 Jun; 2013():. PubMed ID: 23761512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocyte-depleted Hodgkin lymphoma complicating hemophagocytic lymphohistiocytosis as an initial manifestation: a case report and review of the literature.
    Hagihara M; Inoue M; Hua J; Iwaki Y
    Intern Med; 2012; 51(21):3067-72. PubMed ID: 23124152
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced Lymphocyte-rich Classical Hodgkin Lymphoma Complicated with Fatal Hemophagocytic Syndrome.
    Ichikawa S; Takahashi T; Katsushima H; Fukuhara N; Ichinohasama R; Harigae H
    Intern Med; 2016; 55(2):191-6. PubMed ID: 26781022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hodgkin's lymphoma with HLH and complete remission with brentuximab-based therapy.
    Knox B; Singh D; Mai H; Mirza K
    BMJ Case Rep; 2019 Dec; 12(12):. PubMed ID: 31818889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How important is bleomycin in the adriamycin + bleomycin + vinblastine + dacarbazine regimen?
    Canellos GP; Duggan D; Johnson J; Niedzwiecki D
    J Clin Oncol; 2004 Apr; 22(8):1532-3. PubMed ID: 15084636
    [No Abstract]   [Full Text] [Related]  

  • 8. Rituximab, etoposide, methylprednisolone, high-dose cytarabine, and cisplatin in the treatment of secondary hemophagocytic lymphohistiocytosis with classical Hodgkin lymphoma: a case report and review of the literature.
    Hu S; Bansal P; Lynch D; Rojas Hernandez CM; Dayao Z
    J Med Case Rep; 2016 Dec; 10(1):365. PubMed ID: 27998299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Febrile Hypotensive Reactions Following ABVD Chemotherapy in Patients With EBV-associated Classical Hodgkin Lymphoma.
    Bond DA; Dotson E; Awan FT; Baiocchi RA; Blum KA; Maddocks K
    Clin Lymphoma Myeloma Leuk; 2019 Mar; 19(3):e123-e128. PubMed ID: 30594446
    [No Abstract]   [Full Text] [Related]  

  • 10. Angiokeratoma corporis diffusum in a patient with Hodgkin lymphoma: a new paraneoplastic skin manifestation?
    Han F; Wang P; Li Z; Zheng JH; Wang Q; Xu AE; Wang ZM
    Br J Dermatol; 2013 Jun; 168(6):1351-3. PubMed ID: 23278357
    [No Abstract]   [Full Text] [Related]  

  • 11. How can outcomes be improved for older patients with Hodgkin lymphoma?
    Evens AM; Hong F
    J Clin Oncol; 2013 Apr; 31(12):1502-5. PubMed ID: 23509323
    [No Abstract]   [Full Text] [Related]  

  • 12. Autoimmune hemolytic anemia and classical Hodgkin lymphoma: a case report and literature review.
    Feng Q; Zak D; Daya R
    Clin Adv Hematol Oncol; 2012 Apr; 10(4):270-6. PubMed ID: 22706493
    [No Abstract]   [Full Text] [Related]  

  • 13. Feasibility and efficacy of dose-dense and dose-intense ABVD for high-risk patients with advanced Hodgkin lymphoma.
    D'Arco AM; Califano C; Barone L; Belsito Petrizzi V; Iovino V; Langella M; Maglione V; Rivellini F; De Lorenzo S
    Br J Haematol; 2015 Nov; 171(4):662-5. PubMed ID: 25873239
    [No Abstract]   [Full Text] [Related]  

  • 14. [Toxic epidermal necrolysis during a hemophagocytic syndrome secondary to Hodgkin lymphoma. Report of one case].
    Peña C; Voisin J; González JT; Villegas P
    Rev Med Chil; 2018 Apr; 146(4):523-527. PubMed ID: 29999129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapy alone for early-stage Hodgkin's lymphoma.
    Straus DJ
    N Engl J Med; 2012 Feb; 366(5):470-1. PubMed ID: 22149920
    [No Abstract]   [Full Text] [Related]  

  • 16. Hemoperfusion with CytoSorb to Manage Multiorgan Dysfunction in the Spectrum of Hemophagocytic Lymphohistiocytosis Syndrome in Critically Ill Children.
    Bottari G; Murciano M; Merli P; Bracaglia C; Guzzo I; Stoppa F; Pardeo M; Nunziata J; Del Bufalo F; Genuini L; De Benedetti F; Locatelli F; Cecchetti C
    Blood Purif; 2022; 51(5):417-424. PubMed ID: 34344006
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy alone for early Hodgkin's lymphoma: an emerging option.
    Canellos GP
    J Clin Oncol; 2005 Jul; 23(21):4574-6. PubMed ID: 15837972
    [No Abstract]   [Full Text] [Related]  

  • 18. Reduced versus full doses of irradiation after 3 cycles of combined doxorubicin, bleomycin, vinblastine, and dacarbazine in early stage Hodgkin lymphomas: results of a randomized trial.
    Arakelyan N; Jais JP; Delwail V; Brière J; Moles-Moreau MP; Sénécal D; Berthou C; Desablens B; Colonna P; Andrieu JM;
    Cancer; 2010 Sep; 116(17):4054-62. PubMed ID: 20564152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral sudden hearing loss following ABVD protocol.
    Tazi I; Nafil H; Mahmal L
    J Cancer Res Ther; 2014; 10(1):212. PubMed ID: 24762521
    [No Abstract]   [Full Text] [Related]  

  • 20. [Successful chemotherapy of cancer. Remission of Hodgkin's disease. IV].
    Lopez M
    Clin Ter; 2001; 152(3):203-6. PubMed ID: 11692542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.